Impact of Early Low-Calorie Low-Protein Versus Standard Feeding on Outcomes of Ventilated Adults With Shock

NCT ID: NCT03573739

Last Updated: 2022-04-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

3044 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-07-05

Study Completion Date

2021-12-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Among critically ill patients requiring mechanical ventilation and catecholamines for shock, nearly 40% to 50% die, and functional recovery is often delayed in survivors. International guidelines include early nutritional support (≤48 h after admission), 20-25 kcal/kg/d at the acute phase, and 1.2-2 g/kg/d protein. These targets are rarely achieved in patients with severe critically illnesses. Recent data challenge the wisdom of providing standard amounts of calories and protein during the acute phase of critical illness. Studies designed to improve enteral nutrition delivery showed no outcome benefits with higher intakes. Instead, adding parenteral nutrition to increase intakes was associated with longer ICU stays and more infectious complications. Studies suggest that higher protein intakes during the acute phase may be associated with greater muscle wasting and ICU-acquired weakness. The optimal calorie and protein supply at the acute phase of severe critical illness remains unknown. NUTRIREA-3 will be the first trial to compare standard calorie and protein feeding complying with guidelines to low-calorie low-protein feeding potentially associated with improved muscle preservation, translating into shorter mechanical ventilation and ICU-stay durations, lower ICU-acquired infection rates, lower mortality, and better long-term clinical outcomes. This multicentre, randomized, controlled, open trial will compare, in patients receiving mechanical ventilation and treated with vasoactive agent for shock two strategies for initiating nutritional support at the acute phase of ICU management (D0-D7): early calorie/protein restriction (6 kcal/kg/d/0.2-0.4 g/kg/d, Low group) or standard calorie/protein targets (25 kcal/kg/d/1.0-1.3 g/kg/d, Standard group). Patients in both groups will receive enteral or parenteral nutrition appropriate for their critical illness. Two alternative primary end-points will be evaluated: all-cause mortality by day 90 and time to discharge alive from the ICU. Second end-points will be calories and proteins delivered, nosocomial infections, gastro-intestinal complications, glucose control, liver dysfunctions, muscle function at the time of readiness for ICU discharge and quality of life at 3 months and 1 year after study inclusion.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Critical Illness Shock Mechanical Ventilation Critical Illness Myopathy Nosocomial Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

This multicentre randomised controlled open trial compares two parallel groups of patients receiving mechanical ventilation and vasoactive amine therapy and given early nutritional support according to one of two strategies: early calorie/protein restriction (6 kcal/kg/d/0.2-0.4 g/kg/d: Low group) or standard calorie/protein targets (25 kcal/kg/d/1.0-1.3g/kg/d: Standard group) at the acute phase of ICU management (D0-D7).
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Low group

Patients randomized in the "low group" will receive a low-calorie low-protein nutrition regimen during the acute phase.

Group Type EXPERIMENTAL

low-calorie low-protein

Intervention Type PROCEDURE

In the low-calorie low-protein (Low) group, the calorie target will be 6 kcal/kg/day and the protein target 0.2-0.4 g/kg/d during the acute phase, i.e. from D0 to D7. On D8, the calorie target will be 30 kcal/kg/d and the protein target 1.2-2.0 g/kg/d.

Standard group

Patients randomized in the "standard group" will receive a standard-calorie/standard-protein nutrition regimen during the acute phase.

Group Type ACTIVE_COMPARATOR

standard-calorie/standard-protein

Intervention Type PROCEDURE

In the standard-calorie/standard-protein (Standard) group, the first-line calorie target calculated based on body weight is 25 kcal/kg/day and the protein target 1.0-1.3 g/kg/d during the acute phase, i.e. from D0 to D7. On D8, the calorie target will be 30 kcal/kg/d and the protein target 1.2-2.0 g/kg/d.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

low-calorie low-protein

In the low-calorie low-protein (Low) group, the calorie target will be 6 kcal/kg/day and the protein target 0.2-0.4 g/kg/d during the acute phase, i.e. from D0 to D7. On D8, the calorie target will be 30 kcal/kg/d and the protein target 1.2-2.0 g/kg/d.

Intervention Type PROCEDURE

standard-calorie/standard-protein

In the standard-calorie/standard-protein (Standard) group, the first-line calorie target calculated based on body weight is 25 kcal/kg/day and the protein target 1.0-1.3 g/kg/d during the acute phase, i.e. from D0 to D7. On D8, the calorie target will be 30 kcal/kg/d and the protein target 1.2-2.0 g/kg/d.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Invasive mechanical ventilation started in the ICU within the past 24 h, or started before ICU admission with ICU admission within the past 24 h, for an expected duration of at least 48 hours after inclusion
* Treatment with a vasoactive agent for shock (adrenaline, dobutamine, or noradrenaline)
* Nutritional support expected to be started within 24 h after intubation or within 24 h after ICU admission when mechanical ventilation was started before ICU admission
* Age older than 18 years
* Patient and/or next-of-kin informed about the study and having consented to participation in the study. If the patient is unable to receive information and no next-of-kin can be contacted during screening for the study, trial inclusion will be completed as an emergency procedure by the ICU physician, in compliance with the French law.

Exclusion Criteria

* Specific nutritional needs, such as pre-existing long-term home enteral or parenteral nutrition, for chronic bowel disease
* Dying patient, not-to-be-resuscitated order, or other treatment limitation decision at ICU admission
* Pregnancy, recent delivery, or lactation
* Adult under guardianship
* Department of corrections inmate
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ministry of Health, France

OTHER_GOV

Sponsor Role collaborator

University Hospital, Tours

OTHER

Sponsor Role collaborator

Nantes University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jean Reignier, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Nantes University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Chu de La Reunion Site Nord

Saint-Denis, La Réunion, France

Site Status

Chu Amiens Picardie

Amiens, , France

Site Status

CHU Angers

Angers, , France

Site Status

Centre Hospitalier D'Angouleme

Angoulême, , France

Site Status

Ch Annecy-Genevois

Annecy, , France

Site Status

Centre Hospitalier D'Argenteuil

Argenteuil, , France

Site Status

Hôpital du bois brulé

Beauvais, , France

Site Status

Hôpital Nord Franche Comté

Belfort, , France

Site Status

Chu Jean Minjoz

Besançon, , France

Site Status

Hôpital de Béthune

Béthune, , France

Site Status

Hôpital Avicenne AP-HP

Bobigny, , France

Site Status

Hopital Pellegrin Chu

Bordeaux, , France

Site Status

CHU Cavale Blanche

Brest, , France

Site Status

Ch Chartres Louis Pasteur

Chartres, , France

Site Status

Chu Gabriel Montpied

Clermont-Ferrand, , France

Site Status

Hopital Louis Mourier (Ap-Hp)

Colombes, , France

Site Status

Ch Dieppe

Dieppe, , France

Site Status

Chu Bocage

Dijon, , France

Site Status

Hôpital Raymond-Poincaré

Garches, , France

Site Status

Hôpital Michalon

Grenoble, , France

Site Status

Chd Les Oudairies

La Roche-sur-Yon, , France

Site Status

Chu Bicetre

Le Kremlin-Bicêtre, , France

Site Status

Centre Hospitalier Du Mans

Le Mans, , France

Site Status

CH Emile Roux

Le Puy-en-Velay, , France

Site Status

Centre Hospitalier de Lens

Lens, , France

Site Status

Chr - Hopital Roger Salengro

Lille, , France

Site Status

CH Saint-Philibert

Lomme, , France

Site Status

Hopital de La Croix-Rousse

Lyon, , France

Site Status

Hopital Edouard Herriot

Lyon, , France

Site Status

Centre Hospitalier Marc Jacquet

Melun, , France

Site Status

Centre Hospitalier de Montauban

Montauban, , France

Site Status

Hopital Saint Eloi

Montpellier, , France

Site Status

Ctre Hosp Intercomm Andre Gregoire

Montreuil, , France

Site Status

Chu de Nantes

Nantes, , France

Site Status

CHU Nantes

Nantes, , France

Site Status

Chr D'Orleans

Orléans, , France

Site Status

Hopital Lariboisiere

Paris, , France

Site Status

Hôpital Saint Louis (AP-HP)

Paris, , France

Site Status

Hopital Saint Antoine

Paris, , France

Site Status

Hopital Pitie Salpetriere

Paris, , France

Site Status

CHU Paris Cochin

Paris, , France

Site Status

G.I.H. Bichat / Claude Bernard (Ap-Hp)

Paris, , France

Site Status

Hopital Europeen Georges Pompidou

Paris, , France

Site Status

CH Pau

Pau, , France

Site Status

Chu La Miletrie

Poitiers, , France

Site Status

C.H.R. Pontchaillou

Rennes, , France

Site Status

C.H. de Rodez Hopital Jacques Puel

Rodez, , France

Site Status

Hopital Charles Nicolle Chu Rouen

Rouen, , France

Site Status

CH Saint Brieuc

Saint-Brieuc, , France

Site Status

Ch General Delafontaine

Saint-Denis, , France

Site Status

CHU de Saint Etienne

Saint-Priest-en-Jarez, , France

Site Status

Hopital Broussais

St-Malo, , France

Site Status

Hôpital de Hautepierre CHU de Strasbourg

Strasbourg, , France

Site Status

Hopital Foch

Suresnes, , France

Site Status

CH de Bigorre

Tarbes, , France

Site Status

CHU DE TOURS Bretonneau

Tours, , France

Site Status

CH Valenciennes

Valenciennes, , France

Site Status

Centre Hospitalier Bretagne Atlantique - Vannes Auray

Vannes, , France

Site Status

CHU Pointe à Pitre - Abymes

Pointe-à-Pitre, , Guadeloupe

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France Guadeloupe

References

Explore related publications, articles, or registry entries linked to this study.

Reignier J, Plantefeve G, Mira JP, Argaud L, Asfar P, Aissaoui N, Badie J, Botoc NV, Brisard L, Bui HN, Chatellier D, Chauvelot L, Combes A, Cracco C, Darmon M, Das V, Debarre M, Delbove A, Devaquet J, Dumont LM, Gontier O, Groyer S, Guerin L, Guidet B, Hourmant Y, Jaber S, Lambiotte F, Leroy C, Letocart P, Madeux B, Maizel J, Martinet O, Martino F, Maxime V, Mercier E, Nay MA, Nseir S, Oziel J, Picard W, Piton G, Quenot JP, Reizine F, Renault A, Richecoeur J, Rigaud JP, Schneider F, Silva D, Sirodot M, Souweine B, Tamion F, Terzi N, Thevenin D, Thiery G, Thieulot-Rolin N, Timsit JF, Tinturier F, Tirot P, Vanderlinden T, Vinatier I, Vinsonneau C, Voicu S, Lascarrou JB, Le Gouge A; NUTRIREA-3 Trial Investigators; Clinical Research in Intensive Care; Sepsis (CRICS-TRIGGERSEP)Group. Low versus standard calorie and protein feeding in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group trial (NUTRIREA-3). Lancet Respir Med. 2023 Jul;11(7):602-612. doi: 10.1016/S2213-2600(23)00092-9. Epub 2023 Mar 20.

Reference Type DERIVED
PMID: 36958363 (View on PubMed)

Reignier J, Le Gouge A, Lascarrou JB, Annane D, Argaud L, Hourmant Y, Asfar P, Badie J, Nay MA, Botoc NV, Brisard L, Bui HN, Chatellier D, Chauvelot L, Combes A, Cracco C, Darmon M, Das V, Debarre M, Delbove A, Devaquet J, Voicu S, Aissaoui-Balanant N, Dumont LM, Oziel J, Gontier O, Groyer S, Guidet B, Jaber S, Lambiotte F, Leroy C, Letocart P, Madeux B, Maizel J, Martinet O, Martino F, Mercier E, Mira JP, Nseir S, Picard W, Piton G, Plantefeve G, Quenot JP, Renault A, Guerin L, Richecoeur J, Rigaud JP, Schneider F, Silva D, Sirodot M, Souweine B, Reizine F, Tamion F, Terzi N, Thevenin D, Thiery G, Thieulot-Rolin N, Timsit JF, Tinturier F, Tirot P, Vanderlinden T, Vinatier I, Vinsonneau C, Maugars D, Giraudeau B. Impact of early low-calorie low-protein versus standard-calorie standard-protein feeding on outcomes of ventilated adults with shock: design and conduct of a randomised, controlled, multicentre, open-label, parallel-group trial (NUTRIREA-3). BMJ Open. 2021 May 11;11(5):e045041. doi: 10.1136/bmjopen-2020-045041.

Reference Type DERIVED
PMID: 33980526 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RC18_0006

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Efficient PICU Fluid Care Evaluation
NCT06644508 NOT_YET_RECRUITING NA
The Energy Dose Study
NCT01369147 TERMINATED PHASE2
ICU Norepinephrine Load
NCT05032261 COMPLETED